Breast Cancer Detection and Imaging using Analyzer-less X-ray Interferometry
使用无分析仪 X 射线干涉测量法进行乳腺癌检测和成像
基本信息
- 批准号:10057610
- 负责人:
- 金额:$ 24.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-10 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AlgorithmsBiopsyBreastBreast Cancer DetectionBreast Cancer Early DetectionBreast DiseasesCessation of lifeClinicalClinical TrialsCompton radiationComputer softwareCustomDeath RateDetectionDiagnosisDiagnosticDiagnostic ImagingDiagnostic radiologic examinationDoseEarly DiagnosisEvaluationFDA approvedFutureGenerationsGeometryGermanyGoalsHealth Care CostsHospitalsHumanImageImaging technologyInterferometryKnowledgeLeadMammary Gland ParenchymaMammographic screeningMammographyMastectomyMeasuresMethodsModalityModelingOpticsOutcomePathologicPathologyPathway interactionsPatient-Focused OutcomesPatientsPerformancePhaseProcessRadiation Dose UnitRadiation exposureRecoveryReportingRoentgen RaysRunningSamplingSavingsScanningSensitivity and SpecificitySourceSpecificitySpecimenSystemTissue SampleTravelUnited StatesWomanabsorptionattenuationbasebreast cancer diagnosisbreast imagingcancer imagingclinically relevantcontrast imagingcostdesigndetectordigitalimaging modalityimaging systemimprovedinnovationmalignant breast neoplasmnovelphysical processprototypequality assuranceradiological imagingradiologistreceptorscreeningsimulation
项目摘要
We propose a novel X-ray interferometry imaging system which is suitable for screening mammography. This
Multi-Contrast Mammography System with Modulated Phase Gratings (MCMS-MPG) provides 3
complementary types of images – conventional attenuation, phase-contrast and dark-field (small-angle-scatter)
– all processed from a single scan with an amount of dose delivered to the patient that is comparable to that of
a standard screening mammogram. The key innovation that makes this screening interferometry imaging
system possible is the modulated phase grating (MPG) which makes high-quality X-ray interference fringes
observable by clinical X-ray detectors even at compact distances (<70cm) without the fluence absorbing
analyzer-grating required for other advanced X-ray interferometry systems. While the key scientific premise of
our system is application independent, in this project we focus on breast cancer application because nearly 1
in 8 women in the United States will develop invasive breast cancer in their lifetime. Screening and early
diagnosis are key to reducing the death rate. Nearly 40 million women per year are screened using
mammography, a widely accepted radiologic imaging method that uses low-energy X-rays. The current
generation of mammography systems yields 92% sensitivity and 84-92% specificity. False positives require
recalls for diagnostic imaging and biopsies, the costs of which run to $7.9 billion/year. Improving the sensitivity
and specificity for screening will therefore have a significant combined impact on breast-cancer diagnosis as
well as related healthcare costs. Our hypothesis is that the additional multi-contrast information that our system
provides, obtained with no more dose to patient than with current screening mammograms, will yield higher
sensitivity and specificity than those for standard screening mammograms. This project has two aims. Aim1:
We will perform comprehensive simulations and develop an iterative recovery method to improve image
quality. The recovery algorithm removes unwanted image degradation effects like incoherent scatter. The
simulator and recovery algorithm will be validated experimentally using digital breast phantoms and an
observer study by radiologists. Aim2: We will build a prototype version of our MCMS-MPG system and
evaluate its performance on human breast pathology samples and mammography quality assurance
phantoms, using radiation doses comparable to screening mammography systems. An observer study with
radiologists will be used for this evaluation.
我们提出了一种新的X射线干涉成像系统,适用于筛查乳腺摄影。这
具有调制相位光栅的多对比度乳腺X射线摄影系统(MCMS-MPG)提供3
图像的补充类型-常规衰减、相衬和暗场(小角度散射)
- 所有这些都是从单次扫描中处理的,其中输送给患者的剂量量与
一个标准的乳房X光筛查使这种筛选干涉成像的关键创新
调制相位光栅(MPG)是一种可以产生高质量X射线干涉条纹的系统
即使在紧凑的距离(<70 cm)下,也可通过临床X射线探测器观察到,
分析仪光栅所需的其他先进的X射线干涉测量系统。虽然关键的科学前提
我们的系统是独立于应用程序的,在这个项目中,我们专注于乳腺癌的应用,因为近1
在美国,每8名女性中就有1人会在其一生中患上浸润性乳腺癌。筛查和早期
诊断是降低死亡率的关键。每年有近4000万妇女使用
乳房X线摄影术,一种广泛接受的放射成像方法,使用低能量X射线。当前
新一代的乳房X线摄影系统产生92%的灵敏度和84-92%的特异性。假阳性需要
用于诊断成像和活组织检查的召回,其成本高达79亿美元/年。提高灵敏度
因此,筛查的特异性将对乳腺癌诊断产生重大的综合影响,
以及相关的医疗费用。我们的假设是,我们的系统所提供的额外的多对比度信息
提供,获得的患者剂量不超过目前的筛查乳房X线照片,将产生更高的
灵敏度和特异性高于标准筛查乳房X线照片。该项目有两个目标。目标1:
我们将进行全面的模拟,并开发一种迭代恢复方法,以改善图像
质量.恢复算法消除了不必要的图像退化效应,如非相干散射。的
模拟器和恢复算法将使用数字乳房模型和
放射科医生的观察员研究。目标2:我们将建立一个原型版本的MCMS-MPG系统,
评估其在人类乳腺病理学样本和乳腺X射线摄影质量保证方面的性能
使用与筛查乳房X线摄影系统相当的辐射剂量。一项观察者研究,
将由放射科医师进行评价。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joyoni Dey其他文献
Joyoni Dey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joyoni Dey', 18)}}的其他基金
Breast Cancer Detection and Imaging using Analyzer-less X-ray Interferometry
使用无分析仪 X 射线干涉测量法进行乳腺癌检测和成像
- 批准号:
10382323 - 财政年份:2020
- 资助金额:
$ 24.31万 - 项目类别:
Breast Cancer Detection and Imaging using Analyzer-less X-ray Interferometry
使用无分析仪 X 射线干涉测量法进行乳腺癌检测和成像
- 批准号:
10213027 - 财政年份:2020
- 资助金额:
$ 24.31万 - 项目类别:
Design and Simulation of a Novel High Performance Cardiac SPECT Camera
新型高性能心脏 SPECT 相机的设计与仿真
- 批准号:
8048916 - 财政年份:2011
- 资助金额:
$ 24.31万 - 项目类别:
Design and Simulation of a Novel High Performance Cardiac SPECT Camera
新型高性能心脏 SPECT 相机的设计与仿真
- 批准号:
8213704 - 财政年份:2011
- 资助金额:
$ 24.31万 - 项目类别:
相似海外基金
Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma
乳腺癌、胰腺癌和多发性骨髓瘤的多模式液体活检早期评估
- 批准号:
10763336 - 财政年份:2023
- 资助金额:
$ 24.31万 - 项目类别:
Development of the new breast biopsy technique using pseudo tomosynthesis image aimed for the accuracy improvement based on the artificial intelligence
开发利用伪断层合成图像的新型乳腺活检技术,旨在基于人工智能提高准确性
- 批准号:
23K17230 - 财政年份:2023
- 资助金额:
$ 24.31万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Liquid-Biopsy Informed Platform Trial to Evaluate Treatment in CDK4/6-Inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
液体活检知情平台试验,用于评估 CDK4/6 抑制剂耐药 ER/HER2 转移性乳腺癌的治疗
- 批准号:
462212 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Operating Grants
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer: A Prospective Study
局部晚期乳腺癌患者新辅助化疗后前哨淋巴结活检:一项前瞻性研究
- 批准号:
10656553 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Using a Liquid Biopsy to Optimize Metastatic Breast Cancer Treatment
使用液体活检优化转移性乳腺癌治疗
- 批准号:
468409 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Operating Grants
Development of a Liquid Biopsy for Early Breast Cancer Detection
开发用于早期乳腺癌检测的液体活检
- 批准号:
468110 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Operating Grants
Novel Ultrasound Based Viscoelasticity Imaging Tool to Reduce Invasive Breast Lesion Biopsy Rate
新型超声粘弹性成像工具可降低乳腺浸润性病变活检率
- 批准号:
10603447 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Development of an ultrasound detectable, migration-resistant biopsy marker for improving care in patients with breast cancer
开发超声波可检测、抗迁移的活检标记物,以改善乳腺癌患者的护理
- 批准号:
10585262 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer: A Prospective Study
局部晚期乳腺癌患者新辅助化疗后前哨淋巴结活检:一项前瞻性研究
- 批准号:
10502586 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
L2M NSERC - A liquid biopsy blood test for breast cancer detection
L2M NSERC - 用于乳腺癌检测的液体活检血液测试
- 批准号:
576550-2022 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Idea to Innovation